Purdue Pharma Says Sackler Releases Are Vital To Ch. 11 Plan
Bankrupt OxyContin maker Purdue Pharma LP is asking a New York bankruptcy judge to approve its Chapter 11 plan as it defends its $4.5 billion settlement with members of the Sackler...To view the full article, register now.
Already a subscriber? Click here to view full article